Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Evotec AG (EVO) vs Alpha Teknova, Inc. (TKNO)

Evotec AG and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Evotec AG and Alpha Teknova, Inc. are of similar size ($539.9M and $498.8M). Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −38.4%) and the higher return on invested capital (0.00% vs −16.9%). Across the 18 metrics below, Evotec AG leads on 12 and Alpha Teknova, Inc. on 6.

Valuation

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.64 11.45 2.25
P/B 0.72 7.99 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.65 11.45 2.56
Earnings yield (40.90%) (3.32%) (2.99%)
Free cash flow yield (36.14%) (1.47%) 0.00%

Profitability

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 34.60% 53.94%
Operating margin (21.35%) (36.19%) 0.00%
Net margin (26.20%) (38.37%) 0.00%
Free cash flow margin 0.00% (16.83%) 0.00%
Return on equity 0.00% (24.19%) (0.40%)
Return on assets 0.00% (16.25%) (3.32%)
Return on invested capital 0.00% (16.93%) 0.00%

Growth

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 12.27% 10.01%
EPS growth (last fiscal year) 44.89% 43.86% —
Revenue growth, 5-year CAGR 9.28% 5.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.21 0.05
Current ratio 2.33 4.49 2.31
Net debt to EBITDA (0.64) 0.75 0.85

Dividend

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Market cap 539.87m 498.76m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack